<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35585515</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2407</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC cancer</Title>
          <ISOAbbreviation>BMC Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Laminin-integrin a6b4 interaction activates notch signaling to facilitate bladder cancer development.</ArticleTitle>
        <Pagination>
          <StartPage>558</StartPage>
          <MedlinePgn>558</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">558</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-022-09645-7</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Laminins are high-molecular weight (400 ~ 900 kDa) proteins in extracellular matrix, which serve as major component of the basal lamina, and play a crucial role in promoting tumor cell migration. This study aimed at characterizing the role of laminin in promoting cancer development, and elucidating the mechanism of tumor progression driven by laminin-Notch signaling in bladder cancer.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">2D collagen/laminin culture system was established and CCK-8/transwell assay was conducted to evaluate the proliferation/migration ability of Biu-87 and MB49 cells cultured on 2D gels. Activation of integrins-Notch1 signaling was determined by western blotting. Orthotopic bladder cancer mice model was established to assess the therapeutic effects of Notch inhibitor.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Our study demonstrated that extracellular laminin can trigger tumor cell proliferation/migration through integrin α6β4/Notch1 signaling in bladder cancer. Inhibition of Telomere repeat-binding factor 3 (TRB3)/Jagged Canonical Notch Ligand 1 (JAG1) signaling suppressed Notch signals activation induced by laminin-integrin axis. In MB49 orthotopic bladder cancer mice model, Notch inhibitor SAHM1 efficiently improved tumor suppressive effects of chemotherapy and prolonged survival time of tumor-bearing mice.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In conclusion, we show that, in bladder cancer, extracellular laminin induced the activation of Notch pathway through integrin α6β4/TRB3/JAG3, and disclosed a novel role of laminin in bladder cancer cells proliferation or migration.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Hao</LastName>
            <ForeName>Nan</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530000, Guangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Yang</LastName>
            <ForeName>Daming</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530000, Guangxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Tianpei</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421200, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Shucheng</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421200, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Xinsheng</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421200, Hunan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Libo</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421200, Hunan, China. chenlibo20928@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Cancer</MedlineTA>
        <NlmUniqueID>100967800</NlmUniqueID>
        <ISSNLinking>1471-2407</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D039161">Integrin alpha6beta4</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007797">Laminin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005109" MajorTopicYN="N">Extracellular Matrix</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D039161" MajorTopicYN="N">Integrin alpha6beta4</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007797" MajorTopicYN="Y">Laminin</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001749" MajorTopicYN="Y">Urinary Bladder Neoplasms</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bladder cancer</Keyword>
        <Keyword MajorTopicYN="N">Integrins</Keyword>
        <Keyword MajorTopicYN="N">Laminin</Keyword>
        <Keyword MajorTopicYN="N">Notch signaling</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>23</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35585515</ArticleId>
        <ArticleId IdType="pmc">PMC9118635</ArticleId>
        <ArticleId IdType="doi">10.1186/s12885-022-09645-7</ArticleId>
        <ArticleId IdType="pii">10.1186/s12885-022-09645-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3322/caac.21492</ArticleId>
            <ArticleId IdType="pubmed">30207593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15(1):25–41. doi: 10.1038/nrc3817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc3817</ArticleId>
            <ArticleId IdType="pubmed">25533674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeGeorge KC, Holt HR, Hodges SC. Bladder Cancer: diagnosis and treatment. Am Fam Physician. 2017;96(8):507–514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29094888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder Cancer: a review. Jama. 2020;324(19):1980–1991. doi: 10.1001/jama.2020.17598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2020.17598</ArticleId>
            <ArticleId IdType="pubmed">33201207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng L, Weaver AL, Leibovich BC, Ramnani DM, Neumann RM, Scherer BG, Nehra A, Zincke H, Bostwick DG. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer. 2000;88(10):2326–2332. doi: 10.1002/(SICI)1097-0142(20000515)88:10&lt;2326::AID-CNCR17&gt;3.0.CO;2-T.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1097-0142(20000515)88:10&lt;2326::AID-CNCR17&gt;3.0.CO;2-T</ArticleId>
            <ArticleId IdType="pubmed">10820355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gontero P, Banisadr S, Frea B, Brausi M. Metastasis markers in bladder cancer: a review of the literature and clinical considerations. Eur Urol. 2004;46(3):296–311. doi: 10.1016/j.eururo.2004.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eururo.2004.04.001</ArticleId>
            <ArticleId IdType="pubmed">15306099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunner A, Tzankov A. The role of structural extracellular matrix proteins in urothelial bladder cancer (review) Biomark Insights. 2007;2:418–427. doi: 10.4137/BMI.S294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4137/BMI.S294</ArticleId>
            <ArticleId IdType="pmc">PMC2717820</ArticleId>
            <ArticleId IdType="pubmed">19662222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sherwood DR. Cell invasion through basement membranes: an anchor of understanding. Trends Cell Biol. 2006;16(5):250–256. doi: 10.1016/j.tcb.2006.03.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2006.03.004</ArticleId>
            <ArticleId IdType="pubmed">16580836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liotta LA. Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 1986;46(1):1–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2998604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aumailley M, Bruckner-Tuderman L, Carter WG, et al.  A simplified laminin nomenclature. Matrix Biol: J Int Soc Matrix Biol. 2005;24(5):326–332. doi: 10.1016/j.matbio.2005.05.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matbio.2005.05.006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosman FT, Stamenkovic I. Functional structure and composition of the extracellular matrix. J Pathol. 2003;200(4):423–428. doi: 10.1002/path.1437.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.1437</ArticleId>
            <ArticleId IdType="pubmed">12845610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hindermann W, Berndt A, Haas KM, Wunderlich H, Katenkamp D, Kosmehl H. Immunohistochemical demonstration of the gamma2 chain of laminin-5 in urinary bladder urothelial carcinoma. Impact for diagnosis and prognosis. Cancer Detect Prev. 2003;27(2):109–115. doi: 10.1016/S0361-090X(03)00025-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0361-090X(03)00025-4</ArticleId>
            <ArticleId IdType="pubmed">12670521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kunitomi H, Kobayashi Y, Wu RC, Takeda T, Tominaga E, Banno K, Aoki D. LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer. J Gynecol Oncol. 2020;31(2):e11. doi: 10.3802/jgo.2020.31.e11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3802/jgo.2020.31.e11</ArticleId>
            <ArticleId IdType="pmc">PMC7044014</ArticleId>
            <ArticleId IdType="pubmed">31912669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akhavan A, Griffith OL, Soroceanu L, Leonoudakis D, Luciani-Torres MG, Daemen A, Gray JW, Muschler JL. Loss of cell-surface laminin anchoring promotes tumor growth and is associated with poor clinical outcomes. Cancer Res. 2012;72(10):2578–2588. doi: 10.1158/0008-5472.CAN-11-3732.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-11-3732</ArticleId>
            <ArticleId IdType="pmc">PMC3354772</ArticleId>
            <ArticleId IdType="pubmed">22589276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Syed V. TGF-β signaling in Cancer. J Cell Biochem. 2016;117(6):1279–1287. doi: 10.1002/jcb.25496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.25496</ArticleId>
            <ArticleId IdType="pubmed">26774024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santarpia L, Lippman SM, El-Naggar AK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16(1):103–119. doi: 10.1517/14728222.2011.645805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14728222.2011.645805</ArticleId>
            <ArticleId IdType="pmc">PMC3457779</ArticleId>
            <ArticleId IdType="pubmed">22239440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bocchicchio S, Tesone M, Irusta G. Convergence of Wnt and notch signaling controls ovarian cancer cell survival. J Cell Physiol. 2019;234(12):22130–22143. doi: 10.1002/jcp.28775.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.28775</ArticleId>
            <ArticleId IdType="pubmed">31087357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li K, Zhang J, Tian Y, He Y, Xu X, Pan W, Gao Y, Chen F, Wei L. The Wnt/β-catenin/VASP positive feedback loop drives cell proliferation and migration in breast cancer. Oncogene. 2020;39(11):2258–2274. doi: 10.1038/s41388-019-1145-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41388-019-1145-3</ArticleId>
            <ArticleId IdType="pubmed">31831834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamada M, Sekiguchi K. Molecular basis of laminin-integrin interactions. Curr Top Membr. 2015;76:197–229. doi: 10.1016/bs.ctm.2015.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/bs.ctm.2015.07.002</ArticleId>
            <ArticleId IdType="pubmed">26610915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nirwane A, Yao Y. Laminins and their receptors in the CNS. Biol Rev Camb Philos Soc. 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Goddi A, Schroedl L, Brey EM, Cohen RN. Laminins in metabolic tissues. Metab Clin Exp. 2021;120(154775).</Citation>
        </Reference>
        <Reference>
          <Citation>Liang J, Li H, Han J, et al.  Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Cell Death Dis. 2020;11(8):614. doi: 10.1038/s41419-020-02858-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-020-02858-3</ArticleId>
            <ArticleId IdType="pmc">PMC7427100</ArticleId>
            <ArticleId IdType="pubmed">32792503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin Y, Shembrey C, Smith J, et al.  Laminin 521 enhances self-renewal via STAT3 activation and promotes tumor progression in colorectal cancer. Cancer Lett. 2020;476:161–169. doi: 10.1016/j.canlet.2020.02.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2020.02.026</ArticleId>
            <ArticleId IdType="pubmed">32105676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meireles Da Costa N, Mendes FA, Pontes B, Nasciutti LE, Ribeiro Pinto LF, Palumbo JA. Potential therapeutic significance of laminin in head and neck squamous carcinomas. Cancers. 2021;13(8).</Citation>
        </Reference>
        <Reference>
          <Citation>Izrailit J, Jaiswal A, Zheng W, Moran MF, Reedijk M. Cellular stress induces TRB3/USP9x-dependent notch activation in cancer. Oncogene. 2017;36(8):1048–1057. doi: 10.1038/onc.2016.276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2016.276</ArticleId>
            <ArticleId IdType="pubmed">27593927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walker C, Mojares E, Del Río HA. Role of extracellular matrix in development and Cancer progression. Int J Mol Sci. 2018;19(10).</Citation>
        </Reference>
        <Reference>
          <Citation>Levental KR, Yu H, Kass L, et al.  Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891–906. doi: 10.1016/j.cell.2009.10.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2009.10.027</ArticleId>
            <ArticleId IdType="pmc">PMC2788004</ArticleId>
            <ArticleId IdType="pubmed">19931152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Özdemir BC, Pentcheva-Hoang T, Carstens JL, et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6):719–734. doi: 10.1016/j.ccr.2014.04.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2014.04.005</ArticleId>
            <ArticleId IdType="pmc">PMC4180632</ArticleId>
            <ArticleId IdType="pubmed">24856586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spada S, Tocci A, Di Modugno F, Nisticò P. Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology. J Exp Clin Cancer Res: CR. 2021;40(1):102. doi: 10.1186/s13046-021-01908-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13046-021-01908-8</ArticleId>
            <ArticleId IdType="pmc">PMC7972229</ArticleId>
            <ArticleId IdType="pubmed">33731188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujita M, Khazenzon NM, Bose S, Sekiguchi K, Sasaki T, Carter WG, Ljubimov AV, Black KL, Ljubimova JY. Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast Cancer Res: BCR. 2005;7(4):R411–R421. doi: 10.1186/bcr1011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/bcr1011</ArticleId>
            <ArticleId IdType="pmc">PMC1175051</ArticleId>
            <ArticleId IdType="pubmed">15987446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aishima S, Matsuura S, Terashi T, Taguchi K, Shimada M, Maehara Y, Tsuneyoshi M. Aberrant expression of laminin gamma 2 chain and its prognostic significance in intrahepatic cholangiocarcinoma according to growth morphology. Mod Pathol. 2004;17(8):938–945. doi: 10.1038/modpathol.3800143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/modpathol.3800143</ArticleId>
            <ArticleId IdType="pubmed">15105812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamamoto H, Kitadai Y, Yamamoto H, Oue N, Ohdan H, Yasui W, Kikuchi A. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells. Gastroenterology. 2009;137(1):242–252. doi: 10.1053/j.gastro.2009.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2009.02.003</ArticleId>
            <ArticleId IdType="pubmed">19582886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsu YL, Wu CY, Hung JY, Lin YS, Huang MS, Kuo PL. Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway. Carcinogenesis. 2013;34(6):1370–1381. doi: 10.1093/carcin/bgt040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/carcin/bgt040</ArticleId>
            <ArticleId IdType="pubmed">23389289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pouliot N, Nice EC, Burgess AW. Laminin-10 mediates basal and EGF-stimulated motility of human colon carcinoma cells via alpha (3) beta (1) and alpha (6) beta (4) integrins. Exp Cell Res. 2001;266(1):1–10. doi: 10.1006/excr.2001.5197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/excr.2001.5197</ArticleId>
            <ArticleId IdType="pubmed">11339819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10(1):9–22. doi: 10.1038/nrc2748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc2748</ArticleId>
            <ArticleId IdType="pmc">PMC4383089</ArticleId>
            <ArticleId IdType="pubmed">20029421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Estrach S, Cailleteau L, Franco CA, Gerhardt H, Stefani C, Lemichez E, Gagnoux-Palacios L, Meneguzzi G, Mettouchi A. Laminin-binding integrins induce Dll4 expression and notch signaling in endothelial cells. Circ Res. 2011;109(2):172–182. doi: 10.1161/CIRCRESAHA.111.240622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.111.240622</ArticleId>
            <ArticleId IdType="pubmed">21474814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soung YH, Gil HJ, Clifford JL, Chung J. Role of α6β4 integrin in cell motility, invasion and metastasis of mammary tumors. Curr Protein Pept Sci. 2011;12(1):23–29. doi: 10.2174/138920311795659399.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/138920311795659399</ArticleId>
            <ArticleId IdType="pubmed">21190525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lakshmanan I, Rachagani S, Hauke R, et al.  MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling. Oncogene. 2016;35(31):4112–4121. doi: 10.1038/onc.2015.478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2015.478</ArticleId>
            <ArticleId IdType="pmc">PMC5745007</ArticleId>
            <ArticleId IdType="pubmed">26751774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karsan A. Notch and integrin affinity: a sticky situation. Sci Signal. 2008;1(2):pe2.</Citation>
        </Reference>
        <Reference>
          <Citation>Rampias T, Vgenopoulou P, Avgeris M, Polyzos A, Stravodimos K, Valavanis C, Scorilas A, Klinakis A. A new tumor suppressor role for the notch pathway in bladder cancer. Nat Med. 2014;20(10):1199–1205. doi: 10.1038/nm.3678.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3678</ArticleId>
            <ArticleId IdType="pubmed">25194568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma L, Chen K, Jiang K, Deng G, Jiang P, Shao J, Yu Z. Emodin inhibits the proliferation and invasion of bladder cancer cells via down-regulating Notch1. Int J Clin Exp Pathol. 2017;10(9):9452–9459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6965949</ArticleId>
            <ArticleId IdType="pubmed">31966818</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
